BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Licciardi PV, Karagiannis TC. Regulation of immune responses by histone deacetylase inhibitors. ISRN Hematol 2012;2012:690901. [PMID: 22461998 DOI: 10.5402/2012/690901] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Zhou Y, Song Z, Liang H, Zhong S, Yu Y, Liu T, Sha H, He L, Gan J. Mercury Induced Tissue Damage, Redox Metabolism, Ion Transport, Apoptosis, and Intestinal Microbiota Change in Red Swamp Crayfish (Procambarus clarkii): Application of Multi-Omics Analysis in Risk Assessment of Hg. Antioxidants 2022;11:1944. [DOI: 10.3390/antiox11101944] [Reference Citation Analysis]
2 Kim Y, Hodzic E, Amgalan B, Saslafsky A, Wojtowicz D, Przytycka TM. Mutational Signatures as Sensors of Environmental Exposures: Analysis of Smoking-Induced Lung Tissue Remodeling. Biomolecules 2022;12:1384. [DOI: 10.3390/biom12101384] [Reference Citation Analysis]
3 Bag A, Schultz A, Bhimani S, Stringfield O, Dominguez W, Mo Q, Cen L, Adeegbe D. Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer. Oncoimmunology 2022;11:2042065. [PMID: 35223194 DOI: 10.1080/2162402X.2022.2042065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Barone S, Cassese E, Alfano AI, Brindisi M, Summa V. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology. J Med Chem 2022. [PMID: 35148101 DOI: 10.1021/acs.jmedchem.1c02067] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Xu J, Mao J, Han X, Shi F, Gao Q, Wang T, Zhang Z, Shan Y, Fang W, Li X. Porcine Epidemic Diarrhea Virus Inhibits HDAC1 Expression To Facilitate Its Replication via Binding of Its Nucleocapsid Protein to Host Transcription Factor Sp1. J Virol 2021;95:e0085321. [PMID: 34232065 DOI: 10.1128/JVI.00853-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Karagiannis D, Rampias T. HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity. Cancers (Basel) 2021;13:3575. [PMID: 34298787 DOI: 10.3390/cancers13143575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dang F, Wei W. Targeting the acetylation signaling pathway in cancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00051-1. [PMID: 33705871 DOI: 10.1016/j.semcancer.2021.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Adamo A, Frusteri C, Pallotta MT, Pirali T, Sartoris S, Ugel S. Moonlighting Proteins Are Important Players in Cancer Immunology. Front Immunol 2020;11:613069. [PMID: 33584695 DOI: 10.3389/fimmu.2020.613069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chan AM, Fletcher S. Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. RSC Med Chem 2021;12:178-96. [PMID: 34046608 DOI: 10.1039/d0md00286k] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Mohammadi S, Abdollahi E, Nezamnia M, Esmaeili SA, Tavasolian F, Sathyapalan T, Sahebkar A. Adoptive transfer of Tregs: A novel strategy for cell-based immunotherapy in spontaneous abortion: Lessons from experimental models. Int Immunopharmacol 2021;90:107195. [PMID: 33278746 DOI: 10.1016/j.intimp.2020.107195] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Kim YD, Park SM, Ha HC, Lee AR, Won H, Cha H, Cho S, Cho JM. HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment. J Cancer 2020;11:4059-72. [PMID: 32368288 DOI: 10.7150/jca.44622] [Cited by in Crossref: 22] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
12 Gatla HR, Muniraj N, Thevkar P, Yavvari S, Sukhavasi S, Makena MR. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases. Int J Mol Sci 2019;20:E1110. [PMID: 30841513 DOI: 10.3390/ijms20051110] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
13 Krajewski D, Kaczenski E, Rovatti J, Polukort S, Thompson C, Dollard C, Ser-Dolansky J, Schneider SS, Kinney SRM, Mathias CB. Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses. Front Immunol 2018;9:2414. [PMID: 30405614 DOI: 10.3389/fimmu.2018.02414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
14 Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR, Jochems C, Clavijo PE, Allen CT, Hodge JW, Tsang KY, Schlom J, Gameiro SR. Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. Oncoimmunology 2018;7:e1466018. [PMID: 30377559 DOI: 10.1080/2162402X.2018.1466018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
15 Russell‐hallinan A, Watson CJ, Baugh JA. Epigenetics of Aberrant Cardiac Wound Healing. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 451-91. [DOI: 10.1002/cphy.c170029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Chan E, Chiorean EG, O'Dwyer PJ, Gabrail NY, Alcindor T, Potvin D, Chao R, Hurwitz H. Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors. Cancer Chemother Pharmacol 2018;81:355-64. [PMID: 29238851 DOI: 10.1007/s00280-017-3494-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
17 Briere D, Sudhakar N, Woods DM, Hallin J, Engstrom LD, Aranda R, Chiang H, Sodré AL, Olson P, Weber JS, Christensen JG. The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy. Cancer Immunol Immunother 2018;67:381-92. [PMID: 29124315 DOI: 10.1007/s00262-017-2091-y] [Cited by in Crossref: 54] [Cited by in F6Publishing: 66] [Article Influence: 10.8] [Reference Citation Analysis]
18 Šmahel M. PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression. Int J Mol Sci 2017;18:E1331. [PMID: 28635644 DOI: 10.3390/ijms18061331] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
19 Adeegbe DO, Liu Y, Lizotte PH, Kamihara Y, Aref AR, Almonte C, Dries R, Li Y, Liu S, Wang X, Warner-Hatten T, Castrillon J, Yuan GC, Poudel-Neupane N, Zhang H, Guerriero JL, Han S, Awad MM, Barbie DA, Ritz J, Jones SS, Hammerman PS, Bradner J, Quayle SN, Wong KK. Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer. Cancer Discov 2017;7:852-67. [PMID: 28408401 DOI: 10.1158/2159-8290.CD-16-1020] [Cited by in Crossref: 76] [Cited by in F6Publishing: 89] [Article Influence: 15.2] [Reference Citation Analysis]
20 Hu YT, Wu TC, Yang EC, Wu PC, Lin PT, Wu YL. Regulation of genes related to immune signaling and detoxification in Apis mellifera by an inhibitor of histone deacetylation. Sci Rep 2017;7:41255. [PMID: 28112264 DOI: 10.1038/srep41255] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
21 Chacon JA, Schutsky K, Powell DJ. The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy. Vaccines (Basel) 2016;4:E43. [PMID: 27854240 DOI: 10.3390/vaccines4040043] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
22 Bouchat S, Delacourt N, Kula A, Darcis G, Van Driessche B, Corazza F, Gatot JS, Melard A, Vanhulle C, Kabeya K, Pardons M, Avettand-Fenoel V, Clumeck N, De Wit S, Rohr O, Rouzioux C, Van Lint C. Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1. EMBO Mol Med 2016;8:117-38. [PMID: 26681773 DOI: 10.15252/emmm.201505557] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 8.8] [Reference Citation Analysis]
23 Miraglia E, Nylén F, Johansson K, Arnér E, Cebula M, Farmand S, Ottosson H, Strömberg R, Gudmundsson GH, Agerberth B, Bergman P. Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors. Sci Rep 2016;6:33274. [PMID: 27633343 DOI: 10.1038/srep33274] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
24 Toki S, Goleniewska K, Reiss S, Zhou W, Newcomb DC, Bloodworth MH, Stier MT, Boyd KL, Polosukhin VV, Subramaniam S, Peebles RS Jr. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation. Thorax 2016;71:633-45. [PMID: 27071418 DOI: 10.1136/thoraxjnl-2015-207728] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
25 Fang S, Meng X, Zhang Z, Wang Y, Liu Y, You C, Yan H. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis. Neuromolecular Med 2016;18:134-45. [PMID: 26798022 DOI: 10.1007/s12017-016-8383-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
26 Di Liddo R, Valente S, Taurone S, Zwergel C, Marrocco B, Turchetta R, Conconi MT, Scarpa C, Bertalot T, Schrenk S, Mai A, Artico M. Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. Autoimmunity 2016;:1-11. [PMID: 26789595 DOI: 10.3109/08916934.2015.1134510] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
27 Zhou P, Wu E, Alam HB, Li Y. Histone cleavage as a mechanism for epigenetic regulation: current insights and perspectives. Curr Mol Med 2014;14:1164-72. [PMID: 25323999 DOI: 10.2174/1566524014666141015155630] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
28 Cleophas MC, Crişan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G, Jansen TL, Dinarello CA, Netea MG, Joosten LA. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis 2016;75:593-600. [PMID: 25589513 DOI: 10.1136/annrheumdis-2014-206258] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
29 Haworth KB, Leddon JL, Chen CY, Horwitz EM, Mackall CL, Cripe TP. Going back to class I: MHC and immunotherapies for childhood cancer. Pediatr Blood Cancer 2015;62:571-6. [PMID: 25524394 DOI: 10.1002/pbc.25359] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
30 Yang Q, Wei J, Zhong L, Shi M, Zhou P, Zuo S, Wu K, Zhu M, Huang X, Yu Y, Zhang H, Yin H, Zhou J. Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation. Mol Cell Biol 2015;35:63-75. [PMID: 25332236 DOI: 10.1128/MCB.00805-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
31 Lönnroth C, Andersson M, Asting AG, Nordgren S, Lundholm K. Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer. Int J Oncol 2014;45:2208-20. [PMID: 25340937 DOI: 10.3892/ijo.2014.2686] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
32 Jones RB, O'Connor R, Mueller S, Foley M, Szeto GL, Karel D, Lichterfeld M, Kovacs C, Ostrowski MA, Trocha A, Irvine DJ, Walker BD. Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. PLoS Pathog 2014;10:e1004287. [PMID: 25122219 DOI: 10.1371/journal.ppat.1004287] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 17.8] [Reference Citation Analysis]
33 Martins MD, Castilho RM. Histones: Controlling Tumor Signaling Circuitry. J Carcinog Mutagen 2013;1:1-12. [PMID: 25177526 DOI: 10.4172/2157-2518.S5-001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
34 Vaiserman AM, Pasyukova EG. Epigenetic drugs: a novel anti-aging strategy? Front Genet 2012;3:224. [PMID: 23118737 DOI: 10.3389/fgene.2012.00224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
35 Remoli AL, Marsili G, Battistini A, Sgarbanti M. The development of immune-modulating compounds to disrupt HIV latency. Cytokine Growth Factor Rev 2012;23:159-72. [PMID: 22766356 DOI: 10.1016/j.cytogfr.2012.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]